BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 24784894)

  • 21. Sildenafil citrate improves self-esteem, confidence, and relationships in men with erectile dysfunction: Results from an international, multi-center, double-blind, placebo-controlled trial.
    Althof SE; O'leary MP; Cappelleri JC; Hvidsten K; Stecher VJ; Glina S; King R; Siegel RL;
    J Sex Med; 2006 May; 3(3):521-9. PubMed ID: 16681478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physician-rated patient preference and patient- and partner-rated preference for tadalafil or sildenafil citrate: results from the Canadian 'Treatment of Erectile Dysfunction' observational study.
    Lee J; Pommerville P; Brock G; Gagnon R; Mehta P; Krisdaphongs M; Chan M; Chan J; Dickson R
    BJU Int; 2006 Sep; 98(3):623-9. PubMed ID: 16925764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvements in confidence, sexual relationship and satisfaction measures: results of a randomized trial of tadalafil 5 mg taken once daily.
    Seftel AD; Buvat J; Althof SE; McMurray JG; Zeigler HL; Burns PR; Wong DG
    Int J Impot Res; 2009; 21(4):240-8. PubMed ID: 19536128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychosocial impact and effectiveness of tadalafil among treatment-naïve and previously-treated men with erectile dysfunction in Saudi Arabia and other Gulf-region countries.
    El Khiat Y; Ghazi S; Allam A; Khawaja M; Belger M; Tamer M; Kopernicky V
    Curr Med Res Opin; 2008 Jul; 24(7):1965-73. PubMed ID: 18547465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tadalafil is efficacious in Black American and Hispanic men with erectile dysfunction: results from multiple observations in men with erectile dysfunction in national tadalafil study in the US (MOMENTUS).
    Gomery P; Bullock A; McGettigan J; Munarriz R; Natanegara F; Hague J; Kuepfer C; Ahuja S; Wong D
    Int J Impot Res; 2007; 19(1):76-83. PubMed ID: 16728966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of tadalafil in men with erectile dysfunction with a high prevalence of comorbid conditions: results from MOMENTUS: multiple observations in men with erectile dysfunction in National Tadalafil Study in the US.
    Goldstein I; Kim E; Steers WD; Pryor JL; Wilde DW; Natanegara F; Wong DG; Ahuja S
    J Sex Med; 2007 Jan; 4(1):166-175. PubMed ID: 17233782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction.
    Eardley I; Gentile V; Austoni E; Hackett G; Lembo D; Wang C; Beardsworth A
    BJU Int; 2004 Oct; 94(6):871-7. PubMed ID: 15476525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Self-esteem, confidence, and relationships in Brazilian men with erectile dysfunction receiving sildenafil citrate: a randomized, parallel-group, double-blind, placebo-controlled study in Brazil.
    Glina S; Damião R; Abdo C; Afif-Abdo J; Tseng LJ; Stecher V
    J Sex Med; 2009 Jan; 6(1):268-75. PubMed ID: 19186315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emotional changes in men treated with sildenafil citrate for erectile dysfunction: a double-blind, placebo-controlled clinical trial.
    Moncada I; Martínez-Jabaloyas JM; Rodriguez-Vela L; Gutiérrez PR; Giuliano F; Koskimaki J; Farmer IS; Renedo VP; Schnetzler G
    J Sex Med; 2009 Dec; 6(12):3469-77. PubMed ID: 19796051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of two dosing regimens of tadalafil and patterns of sexual activity in men with diabetes mellitus and erectile dysfunction: Scheduled use vs. on-demand regimen evaluation (SURE) study in 14 European countries.
    Buvat J; van Ahlen H; Schmitt H; Chan M; Kuepfer C; Varanese L
    J Sex Med; 2006 May; 3(3):512-20. PubMed ID: 16681477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing vardenafil and sildenafil in the treatment of men with erectile dysfunction and risk factors for cardiovascular disease: a randomized, double-blind, pooled crossover study.
    Rubio-Aurioles E; Porst H; Eardley I; Goldstein I
    J Sex Med; 2006 Nov; 3(6):1037-1049. PubMed ID: 17100937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Switching patients with erectile dysfunction from sildenafil citrate to tadalafil: results of a European multicenter, open-label study of patient preference.
    Ströberg P; Murphy A; Costigan T
    Clin Ther; 2003 Nov; 25(11):2724-37. PubMed ID: 14693300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of improved erectile function and rate of successful intercourse with improved emotional well-being assessed with the Self-Esteem And Relationship questionnaire in men treated with sildenafil for erectile dysfunction and stratified by age.
    Steidle CP; Stecher VJ; Pace C; Tseng LJ;
    Curr Med Res Opin; 2006 May; 22(5):939-48. PubMed ID: 16709315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Scoring correspondence in outcomes related to erectile dysfunction treatment on a 4-point scale (SCORE-4).
    Cappelleri JC; Bushmakin AG; Symonds T; Schnetzler G
    J Sex Med; 2009 Mar; 6(3):809-19. PubMed ID: 19143915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multicenter, randomized, double-blind, crossover study of patient preference for tadalafil 20 mg or sildenafil citrate 50 mg during initiation of treatment for erectile dysfunction.
    Govier F; Potempa AJ; Kaufman J; Denne J; Kovalenko P; Ahuja S
    Clin Ther; 2003 Nov; 25(11):2709-23. PubMed ID: 14693299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of tadalafil treatment on erectile function recovery following bilateral nerve-sparing radical prostatectomy: a randomised placebo-controlled study (REACTT).
    Montorsi F; Brock G; Stolzenburg JU; Mulhall J; Moncada I; Patel HR; Chevallier D; Krajka K; Henneges C; Dickson R; Büttner H
    Eur Urol; 2014 Mar; 65(3):587-96. PubMed ID: 24169081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of on-demand tadalafil for the treatment of erectile dysfunction in South-East Asian men.
    Guo YL; Zhu JC; Pan TM; Ding Q; Wang YX; Cheong NF; Lim E; Shen W; Venugopalan M; Chan M
    Int J Urol; 2006 Jun; 13(6):721-7. PubMed ID: 16834650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy, safety, and treatment satisfaction of tadalafil versus placebo in patients with erectile dysfunction evaluated at tertiary-care academic centers.
    Carson C; Shabsigh R; Segal S; Murphy A; Fredlund P; Kuepfer C;
    Urology; 2005 Feb; 65(2):353-9. PubMed ID: 15708052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An open-label, multicenter, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in Chinese men naïve to phosphodiesterase 5 inhibitor therapy.
    Bai WJ; Li HJ; Dai YT; He XY; Huang YR; Liu JH; Sorsaburu S; Ji C; Jin JJ; Wang XF
    Asian J Androl; 2015; 17(1):61-7. PubMed ID: 25370206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of the efficacy and tolerability of tadalafil 10 mg and 20 mg in Japanese patients with severe erectile dysfunction.
    Marumo K; Imaoka T; Fujimoto K; Watts S; Stothard D; McGill J
    J Sex Med; 2007 May; 4(3):745-752. PubMed ID: 17087800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.